Clinical Trial Update: HD18 for Advanced Stages in Hodgkins Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial in Hodgkins Lymphoma has completed the study evaluating HD18 for advanced-stage disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• HD18

Snippet

Sponsor: University of Cologne | Conditions: Hodgkins Lymphoma | Phase 3 | Status: COMPLETED